Romidepsin
Romidepsin is a histone deacetylase (HDAC) inhibitor, a class of compounds that modulate gene expression by altering the acetylation state of histones and other proteins. It is a cyclic peptide that has been used in research applications to study the effects of HDAC inhibition on cellular processes and disease models.
Lab products found in correlation
2 protocols using romidepsin
Macrocycle Compounds Acquisition Protocol
Macrocycle Compound Acquisition Protocol
are commercially available. Brefeldin
A was purchased from MedChemExpress, romidepsin and troleandomycin
from Focus Biomolecules, simeprevir and paritaprevir from Invivochem,
and pacritinib from Sigma-Aldrich.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!